Today's After-Hours MoversAevi Genomic Medicine, Inc. (NASDAQ: GNMX) 70.4% LOWER; announced that the ASCEND trial, a genomically-guided Phase 2 double-blind ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Aevi (GNMX) PT Lowered to $0.20 at JefferiesJanuary 3, 2019 12:35 PM Qualcomm (QCOM) Posts Security Bonds to Enforce Permanent Injunction Against Apple (AAPL) iPhones in GermanyJanuary 3, 2019 9:03 AM Apple (AAPL) PT Lowered to $180 at Needham & Company Following Pre-Announcement January 3, 2019 7:08 AM Apple (AAPL) PT Lowered to $187 at Piper Jaffray Following Pre-Release January 3, 2019 7:02 AM Lumentum (LITE) PT Lowered to $65 at Needham & Company Following AAPL Pre-Release January 3, 2019 6:36 AM Progenics Pharma (PGNX), Curium Report European Collaboration for Prostate Cancer Imaging Agent PyLJanuary 3, 2019 6:00 AM